DIANTHUS THERAPEUTICS INC DNTH
COM · Common Stock · CUSIP 252828108
Biotechnology company
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersNew York, NY
- Websitemagentatx.com
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 14.8m as of 2023-11-09, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $13.53. Options: 2 managers hold calls ($3.8k notional), 1 hold puts ($0).
Trends to Q3 2023
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q4 2022 | $0 | $0 | — |
| Q1 2023 | $0 | $0 | — |
| Q2 2023 | $0 | $0 | — |
| Q3 2023 | $3.8k | $0 | 0.00 |
Biggest buyers
| FMR LLC | New | +2.2m |
| Fairmount Funds Management LLC | New | +1.9m |
| 5AM Venture Management, LLC | New | +1.5m |
| Avidity Partners Management LP | New | +1.2m |
| Venrock Adviser, LLC | New | +927.7k |
| TANG CAPITAL MANAGEMENT LLC | New | +591.6k |
| Octagon Capital Advisors LP | New | +480.0k |
| Nantahala Capital Management, LLC | New | +336.9k |
| Atlas Venture Life Science Advisors, LLC | New | +237.0k |
| Alphabet Inc. | New | +208.7k |
Biggest sellers
| None |
Biggest calls
| CITADEL ADVISORS LLC | New | $3.8k276 shares |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | New | $00 shares |
Biggest puts
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | New | $00 shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| FMR LLC 13G · institution +1.0 pts · filed 2025-11-05 | 15.0% |
| T. Rowe Price Investment Management, Inc. 13G · institution +5.0 pts · filed 2026-08-07 | 12.1% |
| BlackRock, Inc. 13G · institution +1.3 pts · filed 2026-07-28 | 6.4% |
| WELLINGTON MANAGEMENT GROUP LLP 13G · institution +1.1 pts · filed 2026-08-13 | 5.9% |
Fell to 5% or below in the last year: Sirenia Capital Management LP (3.1%, 2026-08-14), RA CAPITAL MANAGEMENT, L.P. (4.8%, 2026-05-15), Point72 Asset Management, L.P. (1.2%, 2026-05-15), Octagon Capital Advisors LP (3.6%, 2026-05-14), Fairmount Funds Management LLC (4.9%, 2025-11-25)
Insider purchases and sales in Q3 2023
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q4 2021 | 0 | — | 0 | — | — |
| Q1 2022 | 0 | — | 0 | — | — |
| Q2 2022 | 0 | — | 0 | — | — |
| Q3 2022 | 0 | — | 0 | — | — |
| Q4 2022 | 0 | — | 0 | — | — |
| Q1 2023 | 0 | — | 0 | — | — |
| Q2 2023 | 0 | — | 0 | — | — |
| Q3 2023 | 2 | $1.5m | 0 | — | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2023-09-29 | Harwin Peter Evan +2 Director · See footnote | Bought | $336.3k24.7k shares |
| 2023-09-26 | Harwin Peter Evan +2 Director · See footnote | Bought | $394.5k30.0k shares |
| 2023-09-22 | Randhawa Simrat Chief Medical Officer | Bought | $26.4k2.0k shares |
| 2023-09-21 | Randhawa Simrat Chief Medical Officer | Bought | $26.4k2.0k shares |
| 2023-09-19 | Harwin Peter Evan +2 Director · See footnote | Bought | $396.0k30.0k shares |
| 2023-09-13 | Harwin Peter Evan +2 Director · See footnote | Bought | $110.2k9.4k shares |
| 2023-09-12 | Harwin Peter Evan +2 Director · See footnote | Bought | $161.5k14.9k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q3 2023
| Manager | Shares | Change |
|---|---|---|
| FMR LLC 0.00% of their portfolio | 2.2m $29.0m | New |
| Fairmount Funds Management LLC 3.17% of their portfolio | 1.9m $26.4m | New |
| 5AM Venture Management, LLC 5.79% of their portfolio | 1.5m $20.1m | New |
| Avidity Partners Management LP 0.67% of their portfolio | 1.2m $16.6m | New |
| Venrock Adviser, LLC 1.33% of their portfolio | 927.7k $12.7m | New |
| TANG CAPITAL MANAGEMENT LLC 1.14% of their portfolio | 591.6k $8.1m | New |
| Octagon Capital Advisors LP 1.16% of their portfolio | 480.0k $6.6m | New |
| Nantahala Capital Management, LLC 0.58% of their portfolio | 336.9k $4.6m | New |
| Atlas Venture Life Science Advisors, LLC 0.50% of their portfolio | 237.0k $3.2m | New |
| Alphabet Inc. 0.18% of their portfolio | 208.7k $2.9m | New |
| VANGUARD GROUP INC 0.00% of their portfolio | 126.9k $1.7m | New |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 105.6k $1.4m | New |
| Laurion Capital Management LP 0.01% of their portfolio | 36.4k $497.5k | New |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 35.2k $481.0k | New |
| BlackRock Inc. 0.00% of their portfolio | 32.2k $439.5k | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 26.3k $360.2k | New |
| ACADIAN ASSET MANAGEMENT LLC 0.00% of their portfolio | 22.3k $303.0k | New |
| ArrowMark Colorado Holdings LLC 0.00% of their portfolio | 20.8k $284.2k | New |
| RBF Capital, LLC 0.01% of their portfolio | 15.7k $214.3k | New |
| BESSEMER GROUP INC 0.00% of their portfolio | 14.8k $203.0k | New |
| Jefferies Financial Group Inc. 0.00% of their portfolio | 13.2k $180.4k | New |
| CITIGROUP INC 0.00% of their portfolio | 3.9k $52.9k | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 339 $4.0k | New |
| UBS Group AG 0.00% of their portfolio | 319 $4.4k | New |
| MORGAN STANLEY 0.00% of their portfolio | 155 $2.1k | New |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 122 $1.7k | New |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 50 $684 | New |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 41 $560 | New |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 0.00% of their portfolio | 3 $41 | New |
| Qube Research & Technologies Ltd 0.00% of their portfolio | 3 $41 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | New |